# ADROVANCE 70 MG/2.800 UI COMPRIMIDOS , 4 comprimidos · 70 mg/2.800 UI



## Spain

- **AEMPS** — [es.dose-10060.org](https://es.dose-10060.org)

## Codes

- **cn** — `658667`
- **es-registration** — `06364002`
- **gtin-maker** — `00191778001105`
- **gtin-maker** — `00840164500073`
- **gtin-maker** — `00840164523560`
- **gtin-ntin-calculated** — `08470006586679`

## Status

- **lifecycle** — current
- **marketed** — True
- **marketing_date** — 2011-03-21
- **pack_status** — Autorizado
- **pack_status_date** — 2007-03-05
- **effective** — 2007-03-05
- **read** — 2026-11-16T04:47:53Z

## Holder

- ORGANON N.V.
- ORGANON SALUD S.L.

## Proof

Record es:presentation:cn:658667 version 4, signed ES256 under dosidal-record-1.9dbf5d53.

## Related records in other markets

- [Adrovance 70 mg - 70 µg](https://dosidal.ai/pack/be/294357-01) — BE — same product (EU central number)
- [ADROVANCE](https://dosidal.ai/pack/cz/0027978) — CZ — same product (EU central number)
- [Adrovance](https://dosidal.ai/pack/eu/EU-1-06-364-002) — EU — same product (EU central number)
- [ADROVANCE 70 MG/2800 NE TABLETTA](https://dosidal.ai/pack/hu/210408383) — HU — same product (EU central number)
- [ADROVANCE 70 mg/2800 IU tablety](https://dosidal.ai/pack/sk/37850) — SK — same product (EU central number)

A link shows how two records are related. It does not say one product can be used in place of another.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
